Results 251 to 260 of about 331,825 (303)

Older Age and Outcomes of Intravesical Bacillus Calmette-Guérin for Non-muscle-invasive Bladder Cancer. [PDF]

In Vivo
Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T.   +5 more
europepmc   +1 more source

Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential. [PDF]

Front Oncol
Pan M, Tao T, Kong D, Gong H.
europepmc   +1 more source

'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026. [PDF]

BJU Int
Packiam VT, Black PC, Catto JWF, Ghodoussipour S, Kates M, Kamat AM, Lotan Y, O'Donnell MA, Teoh JYC, Thalmann GN, Williams SB.   +10 more
europepmc   +1 more source

Clinical Outcomes in Bacillus Calmette-Guérin-Exposed Non-Muscle-Invasive Bladder Cancer.

JAMA Netw Open
Giatsoglou M, Chatzistavrou D, Sopczynski JM, Feng G, Li R.   +4 more
europepmc   +1 more source

Editorial concerning “Pelvic lymph node dissection may be limited on the contralateral side in strictly unilateral bladder cancer without compromising oncological radicality”

Bladder Cancer
doaj   +1 more source

Bladder cancer [PDF]

Nature Reviews Disease Primers, 2017
Bladder cancer is a highly prevalent disease and is associated with substantial morbidity, mortality and cost. Environmental or occupational exposures to carcinogens, especially tobacco, are the main risk factors for bladder cancer. Most bladder cancers are diagnosed after patients present with macroscopic haematuria, and cases are confirmed after ...
Oner Sanli, Jakub Dobruch, Margaret A Knowles   +2 more
exaly   +3 more sources

Bladder cancer

Nature Reviews Disease Primers, 2023
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways depending on whether the disease is non-muscle invasive or muscle invasive. The mutational burden is higher in muscle-invasive than in non-muscle-invasive disease.
Lars Dyrskjøt, Donna E Hänsel, Jason A Efstathiou   +2 more
exaly   +4 more sources